Guggenheim Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-119,705
| Closed | -$2.15M | – | 1978 |
|
|
2020
Q2 | $2.15M | Buy |
119,705
+49,420
| +70% | +$687K | 0.02% | 857 |
|
|
2020
Q1 | $501K | Sell |
70,285
-13,797
| -16% | -$172K | 0.01% | 1371 |
|
|
2019
Q4 | $2.01M | Buy |
84,082
+18,170
| +28% | +$501K | 0.02% | 1043 |
|
|
2019
Q3 | $1.77M | Sell |
65,912
-5,056
| -7% | -$142K | 0.01% | 1065 |
|
|
2019
Q2 | $1.93M | Sell |
70,968
-810
| -1% | -$25.4K | 0.02% | 1073 |
|
|
2019
Q1 | $2.49M | Sell |
71,778
-20,948
| -23% | -$604K | 0.02% | 979 |
|
|
2018
Q4 | $1.81M | Sell |
92,726
-839
| -0.9% | -$17.3K | 0.02% | 1095 |
|
|
2018
Q3 | $2.49M | Buy |
93,565
+17,835
| +24% | +$582K | 0.02% | 1117 |
|
|
2018
Q2 | $2.86M | Sell |
75,730
-3,624
| -5% | -$139K | 0.02% | 1035 |
|
|
2018
Q1 | $2.59M | Buy |
79,354
+11,544
| +17% | +$507K | 0.01% | 1448 |
|
|
2017
Q4 | $3.3M | Sell |
67,810
-52,552
| -44% | -$2.66M | 0.01% | 1286 |
|
|
2017
Q3 | $6.5M | Buy |
120,362
+34,213
| +40% | +$2.01M | 0.02% | 904 |
|
|
2017
Q2 | $4.84M | Buy |
86,149
+9,820
| +13% | +$393K | 0.01% | 1031 |
|
|
2017
Q1 | $2.99M | Sell |
76,329
-21,778
| -22% | -$694K | 0.01% | 1352 |
|
|
2016
Q4 | $2.2M | Sell |
98,107
-5,372
| -5% | -$105K | 0.01% | 1601 |
|
|
2016
Q3 | $2.35M | Buy |
103,479
+1,673
| +2% | +$39.3K | 0.01% | 1517 |
|
|
2016
Q2 | $2.4M | Buy |
101,806
+5,157
| +5% | +$127K | 0.01% | 1449 |
|
|
2016
Q1 | $1.97M | Sell |
96,649
-13,789
| -12% | -$437K | 0.01% | 1580 |
|
|
2015
Q4 | $5.68M | Sell |
110,438
-39,690
| -26% | -$1.92M | 0.02% | 956 |
|
|
2015
Q3 | $6.4M | Sell |
150,128
-15,988
| -10% | -$771K | 0.02% | 928 |
|
|
2015
Q2 | $7.57M | Buy |
166,116
+15,406
| +10% | +$620K | 0.02% | 967 |
|
|
2015
Q1 | $5.72M | Buy |
150,710
+13,711
| +10% | +$471K | 0.01% | 1106 |
|
|
2014
Q4 | $3.88M | Buy |
+136,999
| New | +$3.81M | 0.01% | 1267 |
|
Guggenheim Capital's PTLA Position: Q3 2020 in Review
Guggenheim Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 119,705 shares — an estimated $2.15M sold.
Guggenheim Capital first reported a position in PTLA in Q4 2014 and held it in 23 quarters. The position peaked at $7.57M in Q2 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Guggenheim Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Guggenheim Capital sold 119,705 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.15M.
- Guggenheim Capital first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 23 quarters.
- Guggenheim Capital's Portola Pharmaceuticals, Inc. position peaked at $7.57M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Guggenheim Capital's 13F filing for Q3 2020, filed 13 Nov 2020.